The tumor suppressor p53 encoded by the tumor protein 53 (TP53) gene has been extensively studied since its discovery in 1979 (1, 2). The last four decades have seen the publication of an enormous number of reports on the role of p53 in suppressing cancer formation. These studies have demonstrated that TP53 mutations are the most common genetic alterations in human tumors (3).
展开▼
